Evidence map›Paper›PMID 29805618›Full record

ArticleOncology letters2018

High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.

Yan Zhang, Jiaxuan Zhang, Qin Shen, Wei Yin, Hua Huang, Yifei Liu, Qingfeng Ni

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2019
    Trial
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yan ZhangDepartment of Oncology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Jiaxuan ZhangDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Qin ShenMedical College, Nantong University, Nantong, Jiangsu 226001, P.R. China.
Wei YinDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Hua HuangDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Yifei LiuDepartment of Pathology, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Qingfeng NiDepartment of General Surgery, Affiliated Hospital of Nantong University, Nantong, Jiangsu 226001, P.R. China.
Affiliated Hospital of Nantong University · CNNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nectins are Ca

Indexed as

gastric cancerimmunohistochemistryNectin-4prognosisreverse transcription-quantitative polymerase chain reaction

Identifiers

PMID29805618
PMCPMC5950544
OpenAlexW2794548855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.